PPT-HCV drug pricing « The future of HIV & HCV Treatment :

Author : marina-yarberry | Published Date : 2018-12-06

Patents pricing and pharma Special session Pauline Londeix XX International AIDS conference AIDS2014 Melbourne Australia Acknowledgments Special thank to Françoise

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "HCV drug pricing « The future of HIV &..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

HCV drug pricing « The future of HIV & HCV Treatment :: Transcript

Patents pricing and pharma Special session Pauline Londeix XX International AIDS conference AIDS2014 Melbourne Australia Acknowledgments Special thank to Françoise BarréSinoussi amp Eric Fleutelot. A . Kamarulzaman. University of Malaya, Kuala Lumpur, Malaysia. Over 1,000 compulsory . centres across Asia. Myanmar, Cambodia, China, Laos, Malaysia, Thailand, and Vietnam. An estimated 400,000 PWUD detained in CCDU . Timothy F Christian, MD, MPA. Characteristics of Big . Pharma. One of OECD largest industries. In US: sales = $380 Billion. R&D costs. =$40 Billion. Single drug to market=$1-4 Billion. The fixed cost in R&D and IP is high. Austrian Branch Report. Vienna, 15 March 2017. Dr. . . Andrea Lahodny. Partner – Transfer Pricing. Dr. . Raffaele . Petruzzi. , LL.M. .. Managing Director, WU Transfer Pricing Center. Transfer . Pricing. Richard A. Rawson, Ph.D, Professor. Semel. Institute for Neuroscience and Human Behavior. David Geffen School of Medicine. University of California at Los Angeles. www.uclaisap.org. rrawson@mednet.ucla.edu. . . Ian Wardle January 2013. . Three different phases of workforce development. 2001-2005 HARM REDUCTION. Building a workforce quickly. 2005-2008 TREATMENT EFFECTIVENESS STRATEGY. A focus on psychosocial competence and quality. 1973, and has since pioneered demand and supply reduction initiative.. DAP is focused . on responding . to multi-faceted . problems on drug use by strengthening programme development in drug demand . Sarah K. Emond, MPP. August 9, 2017. Working Group Charge (draft). This work group will develop for recommendation to the Health Care Cabinet, a proposal to create an actionable plan to align payer contracting with pharmaceutical manufacturers, PBMs, providers and pharmacies that . W. Neil Palmer. President & Principal Consultant. Neil.Palmer@pdci.ca . The Canadian Institute. Drug Pricing & Reimbursement in Canada. Toronto – June 4 & 5, 2013. 1. June 2013. Outline. Richard A. Rawson, Ph.D, Professor. Semel. Institute for Neuroscience and Human Behavior. David Geffen School of Medicine. University of California at Los Angeles. www.uclaisap.org. rrawson@mednet.ucla.edu. . current practice and future capacity.. Vendula. Belackova. 1. Allison Salmon. 1. Eberhard Schatz. 2. Marianne . Jauncey. 1. William Wood. 1. International Network of . Drug Consumption Rooms. 1. John L. LaMattina. CURE / Yale . Biohaven. April 25, 2017. Drug Pricing Now A National Discussion. Turing Pharmaceuticals (Martin Shkreli). raised the price of Daraprim (for toxoplasmosis) from $13.50 to $750 / tablet. . Alison Ritter, Jenny Chalmers, Lynda Berends . Lots of methods to collect drug treatment expenditure. Need standardised methods (for comparison purposes and international harmonisation). International . Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo Sabrina Molinaro, PhD Institute of Clinical Physiology ,National Research Council of Italy (CNR) Lisbon Addiction Conference Kiran Santlal & Adam Shanley. What is Chemsex?. The use of . substances. to . facilitate. or . enhance. sexual experience. Typically . involves . several . participants. Mainly but . not exclusively .

Download Document

Here is the link to download the presentation.
"HCV drug pricing « The future of HIV & HCV Treatment :"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.